Germano Geno J
SEC insider (Form 3/4/5 filer). CIK 0001424383. Director at Eloxx Pharmaceuticals, Inc. (ELOX) and 4 other issuers. 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 19, 2026. Located in ARLINGTON, MA.
Companies Germano Geno J has filed insider reports for
- Eloxx Pharmaceuticals, Inc. (ELOX): Director
- PRECISION BIOSCIENCES INC (DTIL): Director
- Entera Bio Ltd. (ENTX): Director
- Harmony Biosciences Holdings, Inc. (HRMY): Director
- Sage Therapeutics, Inc. (SAGE): Director
Germano Geno J
CIK: 0001424383
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (15 total)
- Oct 19, 2026ELOX
Eloxx Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
13.6K shares- - Sep 25, 2026DTIL
PRECISION BIOSCIENCES INC
PurchaseDirect2.6K shares at avg. $6.28$16K - Aug 7, 2026ENTX
Entera Bio Ltd.
AwardDirect25K shares- - Jun 3, 2026DTIL
PRECISION BIOSCIENCES INC
AwardDirectRestricted Stock Units
21K shares- - May 20, 2026DTIL
PRECISION BIOSCIENCES INC
ExerciseDirect21K shares- - May 14, 2026HRMY
Harmony Biosciences Holdings, Inc.
AwardDirectStock Option
21.2K shares- - Mar 9, 2026ENTX
Entera Bio Ltd.
PurchaseDirect20K shares at avg. $1.30$26K - Feb 10, 2026ENTX
Entera Bio Ltd.
PurchaseDirect20K shares at avg. $1.49$30K - Dec 16, 2025DTIL
PRECISION BIOSCIENCES INC
PurchaseDirect3K shares at avg. $4.72$14K - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
21.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 | ELOX Eloxx Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 13,587 | - | - | Direct |
| Sep 25, 2026 | DTIL PRECISION BIOSCIENCES INC | Purchase | 2,609 | $6.28 | $16,385 | Direct |
| Aug 7, 2026 | ENTX Entera Bio Ltd. | Award | 25,014 | - | $0 | Direct |
| Jun 3, 2026 | DTIL PRECISION BIOSCIENCES INC | Award Restricted Stock Units | 20,979 | - | - | Direct |
| May 20, 2026 | DTIL PRECISION BIOSCIENCES INC | Exercise | 21,000 | - | $0 | Direct |
| May 14, 2026 | HRMY Harmony Biosciences Holdings, Inc. | Award Stock Option | 21,231 | - | - | Direct |
| Mar 9, 2026 | ENTX Entera Bio Ltd. | Purchase | 20,000 | $1.30 | $26,000 | Direct |
| Feb 10, 2026 | ENTX Entera Bio Ltd. | Purchase | 20,000 | $1.49 | $29,800 | Direct |
| Dec 16, 2025 | DTIL PRECISION BIOSCIENCES INC | Purchase | 3,000 | $4.72 | $14,160 | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 21,500 | - | - | Direct |
1-10 of 15 transactions